These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30378231)

  • 1. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
    Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
    Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults.
    McClure EA; Baker NL; Hood CO; Tomko RL; Squeglia LM; Flanagan JC; Carpenter MJ; Gray KM
    Nicotine Tob Res; 2020 Jul; 22(8):1374-1382. PubMed ID: 31612956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking.
    Bold KW; Zweben A; Fucito LM; Piepmeier ME; Muvvala S; Wu R; Gueorguieva R; O'Malley SS
    Alcohol Clin Exp Res; 2019 May; 43(5):937-944. PubMed ID: 30817018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.
    McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM
    Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial.
    Dogar O; Zahid R; Mansoor S; Kanaan M; Ahluwalia JS; Jawad M; Siddiqi K
    Addiction; 2018 Dec; 113(12):2290-2299. PubMed ID: 30187978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia.
    Johnstone S; Sorkhou M; Rabin RA; George TP
    Drug Alcohol Depend; 2022 May; 234():109412. PubMed ID: 35395548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
    Dunn KE; Marcus TF; Kim C; Schroeder JR; Vandrey R; Umbricht A
    Nicotine Tob Res; 2016 May; 18(5):1171-9. PubMed ID: 26476459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
    Bedi G; Cooper ZD; Haney M
    Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.
    al'Absi M; Lemieux A; Hodges JS; Allen S
    Addict Biol; 2019 Jul; 24(4):743-753. PubMed ID: 30117237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.
    Jhanjee S; Jain R; Jain V; Gupta T; Mittal S; Goelz P; Schnoll RA
    J Psychoactive Drugs; 2015; 47(4):325-30. PubMed ID: 26317176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
    Schnoll R; Leone F; Veluz-Wilkins A; Miele A; Hole A; Jao NC; Paul Wileyto E; Carroll AJ; Kalhan R; Patel J; Langer C; Lubitz SF; Hitsman B
    Psychooncology; 2019 Mar; 28(3):561-569. PubMed ID: 30680852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Lim AC; Roche DJO; Ray LA
    J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.
    Rabin RA; Ashare RL; Schnoll RA; Cinciripini PM; Hawk LW; Lerman C; Tyndale RF; George TP
    Am J Addict; 2016 Jun; 25(4):291-6. PubMed ID: 27187893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.